Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Comparative Study of the Efficacy of Treatment of Idiopathic Overactive Bladder (OAB) in Children: Oxybutynine vs. Transcutaneous Neurostimulation [NA]
This clinical trial is currently recruiting to compare oxybutynin with transcutaneous neurostimulation for pediatric overactive bladder.
-
CLINICAL_TRIALS other · 2025-11-12Clinical Trial Update: Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy [Phase 1, Phase 2]
This clinical trial update covers long-term follow-up of patients who received EG110A, a non-replicative HSV-1–derived gene therapy, in Phas…
-
FDA approval · 2025-11-04FDA Approved: MIRABEGRON — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC's generic Mirabegron for the treatment of overactive bladder.
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder [NA]
This clinical trial update records termination of a study comparing Transcutaneous Electrical Nerve Stimulation (TENS) with posterior tibial…
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women [NA]
The APPROVE trial update reports evaluation of a prescription digital therapeutic for treating overactive bladder in women, with the study c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural Women [NA]
Clinical trial evaluating at-home transcutaneous tibial nerve stimulation for overactive bladder in rural women; the study is currently recr…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Tensi+ European Registry
A registry-style trial update indicating that recruiting for the Tensi+ European Registry for overactive bladder is ongoing.
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: A Prospective Evaluation of a Prescription Digital Therapeutic for Treatment of Overactive Bladder in Women: The RiSolve Trial [NA]
A prospective evaluation of RiSolve, a prescription digital therapeutic for treating overactive bladder in women, is listed as not yet recru…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Migraine Medication Effects on Urinary Symptoms
A Cleveland Clinic-sponsored clinical trial is studying how a migraine medication affects urinary symptoms, with enrollment by invitation on…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: UCon Treatment of Overactive Bladder (OAB) in Males [NA]
A clinical trial update indicates that UCon for overactive bladder in males is currently recruiting, sponsored by InnoCon Medical.
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial [NA]
This document describes an ongoing randomized trial sponsored by Benha University comparing platelet-rich plasma injections to botulinum tox…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: BlueWind RENOVA iStim™ System for the Treatment of OAB [NA]
Completed clinical trial of BlueWind Medical's RENOVA iStim System for overactive bladder; results were posted on 2025-09-16.
-
CLINICAL_TRIALS other · 2025-09-16Clinical Trial Update: Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy
A clinical trial update describes a study evaluating pelvic floor disorder symptoms in women seeking weight loss therapy. The study is not y…
-
EMA approval · 2025-09-15EMA Authorised: Emselex (darifenacin hydrobromide) — pharmaand GmbH
The EMA authorised Emselex (darifenacin hydrobromide) for urinary incontinence due to urge and overactive bladder, with pharmaand GmbH as th…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections
This clinical trial is investigating how the genitourinary microbiome changes in women with overactive bladder who are receiving intradetrus…
-
CLINICAL_TRIALS other · 2025-09-09Clinical Trial Update: Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks [Phase 4]
Phase 4 clinical trial evaluating urinary microbiome changes after 500 mg of NDS-446 in women with dry overactive bladder; currently recruit…
-
CLINICAL_TRIALS withdrawal · 2025-09-05Clinical Trial Update: The Combined Effect of Intravesical Botox Injections and HoLEP Surgery in Treating Benign Prostatic Hyperplasia and Overactive Bladder [Phase 4]
A Phase 4 trial evaluating the combination of intravesical Botox injections and HoLEP surgery for benign prostatic hyperplasia and overactiv…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: High Intensity Focused Electromagnetic Field Device for Urinary Incontinence [NA]
This entry reports the completion of a clinical trial evaluating a High Intensity Focused Electromagnetic Field device for urinary incontine…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Stimulating Percutaneous Array for Urinary Reflex Control (SPARC) [NA]
Clinical trial update for SPARC evaluating a percutaneous stimulation array to control urinary reflexes in overactive bladder. The trial sta…
-
EMA approval · 2025-08-27EMA Authorised: Betmiga (Mirabegron) — Astellas Pharma Europe B.V.
The European Medicines Agency authorised Betmiga (mirabegron) from Astellas Pharma Europe B.V. for the treatment of overactive bladder (auth…
-
FDA approval · 2025-08-21FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for Tolterodine tartrate (tolterodine) submitted by Torrent Pharmaceuticals Limited, confirming …
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: TENS Used for Pain Management During Office Cystoscopy Botox Injections [NA]
A terminated Mayo Clinic trial evaluating transcutaneous electrical nerve stimulation (TENS) for pain management during office cystoscopy wi…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Electroacupuncture as a Treatment for Refractory Overactive Bladder [NA]
A planned clinical trial is evaluating electroacupuncture as a treatment for refractory overactive bladder. Sponsored by Chelsea and Westmin…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial [Phase 3]
Phase 3 randomized controlled trial evaluating nighttime dosing of mirabegron, solifenacin, tolterodine, or oxybutynin on nocturia and relat…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: The Effect Of Pelvic Floor Muscle Exercises On Sexual Life In Women With Overactive Bladder [NA]
A completed clinical trial evaluated whether pelvic floor muscle exercises impact sexual life in women with overactive bladder.